全文获取类型
收费全文 | 2291篇 |
免费 | 150篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 70篇 |
妇产科学 | 87篇 |
基础医学 | 238篇 |
口腔科学 | 25篇 |
临床医学 | 180篇 |
内科学 | 546篇 |
皮肤病学 | 49篇 |
神经病学 | 187篇 |
特种医学 | 95篇 |
外科学 | 233篇 |
综合类 | 10篇 |
预防医学 | 155篇 |
眼科学 | 7篇 |
药学 | 194篇 |
中国医学 | 8篇 |
肿瘤学 | 349篇 |
出版年
2023年 | 23篇 |
2022年 | 54篇 |
2021年 | 70篇 |
2020年 | 64篇 |
2019年 | 69篇 |
2018年 | 109篇 |
2017年 | 58篇 |
2016年 | 55篇 |
2015年 | 71篇 |
2014年 | 73篇 |
2013年 | 93篇 |
2012年 | 192篇 |
2011年 | 186篇 |
2010年 | 103篇 |
2009年 | 68篇 |
2008年 | 121篇 |
2007年 | 111篇 |
2006年 | 107篇 |
2005年 | 72篇 |
2004年 | 97篇 |
2003年 | 73篇 |
2002年 | 56篇 |
2001年 | 50篇 |
2000年 | 62篇 |
1999年 | 37篇 |
1998年 | 14篇 |
1997年 | 14篇 |
1996年 | 12篇 |
1995年 | 15篇 |
1994年 | 11篇 |
1993年 | 10篇 |
1992年 | 25篇 |
1991年 | 24篇 |
1990年 | 31篇 |
1989年 | 20篇 |
1988年 | 22篇 |
1987年 | 10篇 |
1986年 | 15篇 |
1985年 | 13篇 |
1984年 | 16篇 |
1983年 | 11篇 |
1980年 | 9篇 |
1979年 | 12篇 |
1978年 | 6篇 |
1976年 | 7篇 |
1975年 | 10篇 |
1974年 | 10篇 |
1972年 | 5篇 |
1969年 | 6篇 |
1967年 | 6篇 |
排序方式: 共有2445条查询结果,搜索用时 15 毫秒
91.
92.
93.
94.
Umberto Volpe Hania Amin Olatunde O. Ayinde Alistair Burns Wai Chi Chan Renaud David Slavica Djukic Dejanovic Gorica Djokic Defne Eraslan Giulia A.L. Fischer Patricia Gracia-García Syed Usman Hamdani Changsu Han Hussain Jafri Roy A. Kallivayalil Roderick Leonard Kriekaart Ee Heok Kua Linda C.W. Lam Dusica Lecic-Tosevski Iracema Leroi Antonio Lobo Adriana Mihai Fareed Aslam Minhas Heena Mistry Afolakemi T. Ogundele Marcel G.M. Olde Rikkert Javier Olivera Claudia Palumbo Angela Parker Bojana Pejuskovic Florian Riese Philippe Robert Maya Semrau Gabriela Stoppe Sanu Sudhakar Andreea Raluca Tirintica Sehrish Tofique Chris Tsoi Lucas Wolski Irem Yalug Huali Wang Xin Yu Norman Sartorius 《International journal of geriatric psychiatry》2020,35(2):163-173
95.
Orazio Palmieri Tommaso Mazza Gabrio Bassotti Antonio Merla Salvatore Tolone Tommaso Biagini Antonello Cuttitta Fabrizio Bossa Giuseppina Martino Tiziana Latiano Giuseppe Corritore Domenica Gioffreda Orazio Palumbo Massimo Carella Anna Panza Angelo Andriulli Anna Latiano 《Neurogastroenterology and motility》2020,32(3)
96.
Iris Cervenka Marie Al Rahmoun Yahya Mahamat-Saleh Agnès Fournier Marie-Christine Boutron-Ruault Gianluca Severi Saverio Caini Domenico Palli Reza Ghiasvand Marit B. Veierod Edoardo Botteri Anne Tjønneland Anja Olsen Renée T. Fortner Rudolf Kaaks Matthias B. Schulze Salvatore Panico Antonia Trichopoulou Clio Dessinioti Katerina Niforou Sabina Sieri Rosario Tumino Carlotta Sacerdote Bas Bueno-de-Mesquita Torkjel M. Sandanger Sandra Colorado-Yohar Maria J. Sánchez Leire Gil Majuelo Leila Lujan-Barroso Eva Ardanaz Susana Merino Karolin Isaksson Salma Butt Ingrid Ljuslinder Malin Jansson Ruth C. Travis Kay-Tee Khaw Elisabete Weiderpass Laure Dossus Sabina Rinaldi Marina Kvaskoff 《International journal of cancer. Journal international du cancer》2020,146(12):3267-3280
Evidence suggests an influence of sex hormones on cutaneous melanoma risk, but epidemiologic findings are conflicting. We examined the associations between use of oral contraceptives (OCs) and menopausal hormone therapy (MHT) and melanoma risk in women participating in the European Prospective Investigation into Cancer and Nutrition (EPIC). EPIC is a prospective cohort study initiated in 1992 in 10 European countries. Information on exogenous hormone use at baseline was derived from country-specific self-administered questionnaires. We used Cox proportional hazards regression models to calculate hazard ratios (HRs) and 95% confidence intervals (CIs). Over 1992–2015, 1,696 melanoma cases were identified among 334,483 women, whereof 770 cases among 134,758 postmenopausal women. There was a positive, borderline-significant association between OC use and melanoma risk (HR = 1.12, 95% CI = 1.00–1.26), with no detected heterogeneity across countries (phomogeneity = 0.42). This risk increased linearly with duration of use (ptrend = 0.01). Among postmenopausal women, ever use of MHT was associated with a nonsignificant increase in melanoma risk overall (HR = 1.14, 95% CI = 0.97–1.43), which was heterogeneous across countries (phomogeneity = 0.05). Our findings do not support a strong and direct association between exogenous hormone use and melanoma risk. In order to better understand these relations, further research should be performed using prospectively collected data including detailed information on types of hormone, and on sun exposure, which may act as an important confounder or effect modifier on these relations. 相似文献
97.
98.
Prevalence,severity and correlates of fatigue in newly diagnosed patients with myelodysplastic syndromes 下载免费PDF全文
Fabio Efficace Gianluca Gaidano Massimo Breccia Marianna Criscuolo Francesco Cottone Giovanni Caocci David Bowen Michael Lübbert Emanuele Angelucci Reinhard Stauder Dominik Selleslag Uwe Platzbecker Grazia Sanpaolo Anna Jonasova Francesco Buccisano Giorgina Specchia Giuseppe A. Palumbo Pasquale Niscola Chonghua Wan Huiyong Zhang Susanna Fenu Virginia Klimek Odile Beyne‐Rauzy Khanh Nguyen Franco Mandelli 《British journal of haematology》2015,168(3):361-370
The primary objective of this study was to investigate factors associated with fatigue severity in newly diagnosed patients with higher‐risk myelodysplastic syndromes (MDS). The secondary objectives were to assess symptom prevalence and to examine the relationships between fatigue, quality of life (QoL) and overall symptom burden in these patients. The analyses were conducted in 280 higher‐risk MDS patients. Pre‐treatment patient‐reported fatigue was evaluated with the Functional Assessment of Chronic Illness Therapy (FACIT)‐Fatigue scale and QoL was assessed with the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire‐Core 30 (EORTC QLQ‐C30). Female gender (P = 0·018), poor performance status (i.e., ECOG of 2–4) (P < 0·001) and lower levels of haemoglobin (Hb) (P = 0·026) were independently associated with higher fatigue severity. The three most prevalent symptoms were as follows: fatigue (92%), dyspnoea (63%) and pain (55%). Patients with higher levels of fatigue also had greater overall symptom burdens. The mean global QoL scores of patients with the highest versus those with the lowest levels of fatigue were 29·2 [standard deviation (SD), 18·3] and 69·0 (SD, 18·8), respectively and this difference was four times the magnitude of a clinically meaningful difference. Patient‐reported fatigue severity revealed the effects of disease burden on overall QoL more accurately than did degree of anaemia. Special attention should be given to the female patients in the management of fatigue. 相似文献
99.
Occhiuto F Palumbo DR Samperi S Zangla G Pino A De Pasquale R Circosta C 《Phytotherapy research : PTR》2009,23(2):192-196
Oxidative stress-induced neuronal cell death has been implicated in different neurological disorders and neurodegenerative diseases such as Alzheimer's disease and Parkinson's. Using the Alzheimer's disease-associated hydrogen peroxide (H(2)O(2)), we investigated the neuroprotective efficacy of a natural mixture of phytoestrogenic isoflavones (genistein, daidzein, biochanin A and formononetin) from Trifolium pratense L. (Red clover) against oxidative stress-induced cell death in human cortical cell line HCN 1-A maintained in culture. Neuronal viability was determined by MTT or trypan blue test and neuronal integrity by morphological analysis.The results obtained indicate that exposure of HCN 1-A cell cultures to hydrogen peroxide resulted in a concentration-dependent decrease in neuron viability. Concentration of H(2)O(2) ranging from 50 to 200 microg/ml were toxic to these cultures. A 24-hour pretreatment with 0.5, 1 and 2 microg/ml isoflavones extract significantly increased cell survival as evidenced by MTT or trypan blue test and significantly prevented the morphological disruption caused by H(2)O(2) as shown by microscopical inspection, indicating that neurons treated with isoflavones were protected from the cell death induced by H(2)O(2) exposure. These findings imply that the neuroprotective effect of isoflavones extract is partly associated with its antioxidant activity. Further, results of these investigations indicate that although isoflavones extract exert a neuroprotective effect, it do not promoted cortical neuron process outgrowth. 相似文献
100.
Alberto Giannini Guido Miccinesi Edi Prandi Carlotta Buzzoni Claudia Borreani 《Intensive care medicine》2013,39(12):2180-2187